Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 1 hour ago
Qiagen links with chip giant Nvidia to propel AI use in drug discovery
about 1 hour ago
Qiagen, a Netherlands-based diagnostics maker, is linking with tech giant Nvidia in...
Lilly pens $202M deal for preclinical DNA delivery biotech Engage as M&A streak continues
about 4 hours ago
San Carlos-based Engage is developing non-viral DNA delivery systems that aim to...
With $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate
about 5 hours ago
In the sprawling metropolis of Houston, a new biotech has emerged to...
Incyte pays Genesis $80M to expand AI-fueled drug discovery pact
about 5 hours ago
Incyte is paying Genesis $80 million upfront to expand use of its...
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
about 5 hours ago
BMS is the latest large pharma company to make a major bet...
Labcorp joins lab results personalization push with ‘MyLabcorp’ AI app
about 6 hours ago
The big new thing in medtech for 2026 is AI-powered apps and...
Immunovant pays out $39M to call time on FcRn inhibitor after eye disease phase 3 fails
about 7 hours ago
Immunovant has confirmed that its first-generation FcRn inhibitor has been scrapped, with...
Endologix acquires thrombectomy system from Surmodics
about 7 hours ago
Endologix, a medtech that focuses on treatments for vascular diseases, expanded its...
Parabilis, fresh from inking Regeneron pact, plans IPO to fund tumor drug’s phase 3 push
about 10 hours ago
With the ink barely dry on an antibody-drug conjugate-style deal with Regeneron...
Pfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chief
about 10 hours ago
After decades of developing vaccines to shield babies and adults from Streptococcus...
Clinical trial flaws ‘being scaled, not solved’ by AI: report
1 day ago
Clinical trial data company Phesi’s new analysis found that fewer than one...
Facing mounting China licensing costs, biopharma buyers turn to AI and local know-how to keep up
1 day ago
Chinese companies now represent 50% of global out-licensing deals, with U.S. companies...